Home Newsfeeds Tesla Granted U.S. Patent #11562231: Neural Networks For Embedded Devices

Tesla Granted U.S. Patent #11562231: Neural Networks For Embedded Devices

https://www.scribd.com/document/621583845/Tesla-Patent

byCharles Gross

January 24, 2023

1 minute read

Did Rivian Just Reveal The First Glimpse Of R2 Interior? Not Exactly

By Anan Ashraf

February 8, 3:08 AM

Excitement for the R2 has surged in recent days following the company's announcement on Monday that it would unveil its next-generation EV platform on March 7 at Laguna Beach.

RIVN

FDA Approves Verrica Pharma’s Ycanth: First Treatment Of Molluscum Contagiosum Impacting 6M People In US

By Vandana Singh

July 24, 8:19 AM

The FDA approved Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) Ycanth (cantharidin) topical solution for molluscum contagiosum (molluscum) in adult and pediatric patients

VRCA

Why Motion & Control Technologies Provider Parker-Hannifin Shares Are Higher Today

By Lekha Gupta

February 1, 2:35 PM

Parker-Hannifin shares surge after Q2 FY24 results, outperforming with a 3.1% Y/Y sales growth to $4.821 billion. Aerospace Systems lead with a 15% Y/Y sales rise. The company's financial prowess is evident, boasting increased operating cash flow and a declared quarterly cash dividend of $1.48 per share.

EXCLUSIVE: Decentralized Exchanges Could Face Increased Regulatory Scrutiny, Predicts Bitfinex And Tether CTO Paolo Ardoino

By Murtuza Merchant

June 7, 12:06 PM

Paolo Ardoino, the chief technology officer of Bitfinex and Tether (CRYPTO: USDT), hinted at a potential escalation in regulatory scrutiny aimed at decentralized exchanges (DEXs), even as the U.S.

$BNB

Tesla Granted U.S. Patent #11562231: Neural Networks For Embedded Devices

Related Posts

Did Rivian Just Reveal The First Glimpse Of R2 Interior? Not Exactly

FDA Approves Verrica Pharma’s Ycanth: First Treatment Of Molluscum Contagiosum Impacting 6M People In US

Why Motion & Control Technologies Provider Parker-Hannifin Shares Are Higher Today

EXCLUSIVE: Decentralized Exchanges Could Face Increased Regulatory Scrutiny, Predicts Bitfinex And Tether CTO Paolo Ardoino